SteelPeak Wealth LLC Purchases 23,081 Shares of UnitedHealth Group Incorporated $UNH

SteelPeak Wealth LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 229.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 33,151 shares of the healthcare conglomerate’s stock after purchasing an additional 23,081 shares during the period. SteelPeak Wealth LLC’s holdings in UnitedHealth Group were worth $11,447,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in UNH. Retirement Guys Formula LLC boosted its stake in shares of UnitedHealth Group by 8.2% during the 3rd quarter. Retirement Guys Formula LLC now owns 10,292 shares of the healthcare conglomerate’s stock worth $3,554,000 after acquiring an additional 781 shares during the period. Relyea Zuckerberg Hanson LLC boosted its position in UnitedHealth Group by 13.5% during the third quarter. Relyea Zuckerberg Hanson LLC now owns 4,034 shares of the healthcare conglomerate’s stock worth $1,393,000 after purchasing an additional 480 shares during the period. Discipline Wealth Solutions LLC raised its position in shares of UnitedHealth Group by 24.8% in the third quarter. Discipline Wealth Solutions LLC now owns 1,393 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 277 shares during the period. Schear Investment Advisers LLC grew its stake in UnitedHealth Group by 4.9% in the 3rd quarter. Schear Investment Advisers LLC now owns 4,899 shares of the healthcare conglomerate’s stock valued at $1,692,000 after buying an additional 231 shares during the last quarter. Finally, Three Magnolias Financial Advisors LLC lifted its position in UnitedHealth Group by 9.6% during the third quarter. Three Magnolias Financial Advisors LLC now owns 1,167 shares of the healthcare conglomerate’s stock worth $403,000 after acquiring an additional 102 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on UNH shares. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. KeyCorp boosted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. TD Cowen boosted their price target on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Finally, The Goldman Sachs Group started coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective on the stock. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $330.32 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock has a fifty day moving average of $331.11 and a 200-day moving average of $319.52. The stock has a market capitalization of $299.22 billion, a P/E ratio of 17.24, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company posted $7.15 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.